Evidence map›Paper›PMID 38673750›Full record

ArticleInternational journal of molecular sciences2024

Antimicrobial Activities of α-Helix and

Ruina Bao, Zhi Ma, Kim Stanford, Tim A McAllister, Yan D Niu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Short peptide 803sp inhibits the inflammatory response induced byFrontiers in cellular and infection microbiology · 2026
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Ruina BaoFaculty of Veterinary Medicine, University of Calgary, Calgary, AB T2N 4Z6, Canada.
Zhi MaCollege of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou 310014, China.
Kim StanfordDepartment of Biological Sciences, University of Lethbridge, Lethbridge, AB T1K 3M4, Canada.ORCID 0000-0001-8784-0042
Tim A McAllisterAgriculture and Agri-Food Canada, Lethbridge Research and Development Center, Lethbridge, AB T1J 4B1, Canada.ORCID 0000-0002-8266-6513
Yan D NiuFaculty of Veterinary Medicine, University of Calgary, Calgary, AB T2N 4Z6, Canada.ORCID 0000-0002-4483-5734
University of Calgary · CAAgriculture and Agri-Food Canada · CAUniversity of Lethbridge · CAZhejiang University of Technology · CN

Funding

Alberta Research Capacity Program Not applicableMajor Innovation Fund and Canada Foundation for Innovation (John R. Evans Leaders Fund) 38710Margaret Gunn Endowment for Animal Research Not applicable
6 · The paper itself

Abstract

Bovine respiratory disease (BRD) is the leading cause of morbidity and mortality in cattle raised in North America. At the feedlot, cattle are subject to metaphylactic treatment with macrolides to prevent BRD, a practice that may promote antimicrobial resistance and has resulted in an urgent need for novel strategies.

Indexed as

Antimicrobial PeptidesMannheimia haemolyticaAnimalsAnti-Bacterial AgentsBovine Respiratory Disease ComplexCattleMicrobial Sensitivity TestsProtein Conformation, alpha-HelicalProtein Conformation, beta-StrandAnti-Bacterial AgentsAntimicrobial Peptidesantibacterial activityantimicrobial peptidebovine respiratory diseaseMannheimia haemolytica

Identifiers

PMID38673750
PMCPMC11050306
OpenAlexW4394685785

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.